About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Digestive Tract Cancer and CIPN | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNANCT06331962

Digestive Tract Cancer and CIPN

According to the incidence rate of cancer, the digestive tract cancer accounts for two of the top ten cancers. It also accounts for half of the top ten causes of cancer death. Chemotherapy remains one...

Lead sponsor: National Cheng-Kung University Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Cheng-Feng Lin, Ph.D

CONTACT

886-6-2353535 connie@mail.ncku.edu.tw

Sponsors

Lead Sponsor

National Cheng-Kung University Hospital

Collaborators

National Cheng Kung University

Age

20 - 80 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Age 20 and above;
•2. Diagnosed by a physician with gastrointestinal cancer and has undergone chemotherapy or is currently undergoing chemotherapy;
•3. Diagnosed by a physician with chemotherapy-induced peripheral neuropathy.

Exclusion Criteria

•1. Cognitive impairment or inability to cooperate with verbal instructions;
•2. Neurological, muscular, skeletal, or cardiovascular issues preventing participation in exercise training;
•3. Age 80 or above;
•4. Refusal to engage in exercise intervention or participate in data collection.

Related studies

RECRUITINGPhase 3

Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced Peripheral Neuropathy

NCT05840562 · Chemotherapy-induced Peripheral Neuropathy

RECRUITINGPhase 2

Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN)

NCT07072468 · Chemotherapy-induced Peripheral Neuropathy, Drug-Induced Nephropathy

The Use of Acupuncture to Reduce Chemotherapy Induced Peripheral Neuropathy in Gynaecological Cancer Patients

NCT06769061 · Gynaecological, Urological or Rectal Cancer, Chemotherapy-Induced Peripheral Neuropathy, and more

Exploring the Benefit of Peripheral Nerve Stimulation in Treating Pain From Chemo-induced Peripheral Neuropathy: A Longitudinal Single Center Feasibility Study

NCT06162403 · Peripheral Nerve Stimulation, Chemotherapy-induced Peripheral Neuropathy

VGAIT for Chemotherapy-induced Peripheral Neuropathy

NCT07177820 · Chemotherapy-induced Peripheral Neuropathy

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 26, 2024Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment90

Start dateMay 2023

Last updatedMar 26, 2024

Condition

Digestive Tract Cancer Chemotherapy-induced Peripheral Neuropathy Remote Exercise

Locations shown

Department of Physical Therapy, National Cheng-Kung University

Tainan

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 26, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions